Perfil
Dr. Christophe Reymond is Chief Scientific Officer at Anergis SA.
Dr. Reymond was previously employed as an Assistant Professor by University of Lausanne, Chief Scientific Officer by Dictagene, and Researcher by University of California San Diego.
Antiguos cargos conocidos de Christophe Reymond.
Empresas | Cargo | Fin |
---|---|---|
Dictagene | Founder | 01/01/2005 |
University of Lausanne | Corporate Officer/Principal | 01/01/2001 |
University of California San Diego | Corporate Officer/Principal | - |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |
Dictagene |
- Bolsa de valores
- Insiders
- Christophe Reymond